We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Innovative Device Measures Glucose in Saliva for More Convenient Diabetes Monitoring

By LabMedica International staff writers
Posted on 30 Aug 2023

Diabetes arises when the body fails to regulate its blood glucose levels. More...

Elevated glucose levels can lead to cardiovascular disease and other ailments, making it essential for individuals with diabetes to keep their blood glucose within moderate ranges. The conventional method for monitoring blood glucose in people with diabetes involves using devices that analyze a droplet of blood obtained through finger pricking multiple times daily. Recently, implanted sensors have enabled continuous glucose monitoring without the discomfort of pinpricks, but these devices might be less accurate for lower glucose levels and are not approved for children. A more convenient alternative could be salivary testing, as saliva correlates with blood glucose levels. However, glucose concentrations in saliva are much lower than in blood, posing challenges for accurate measurement without advanced laboratory equipment.

Researchers at King Abdullah University of Science and Technology (KAUST, Saudi Arabia) have now created a prototype sensor capable of measuring glucose levels in saliva. This innovation could eventually offer a simple, swift, and painless way for individuals to monitor their diabetes. The KAUST team devised a remarkably sensitive glucose detector built on a thin-film transistor. These compact, lightweight, and energy-efficient devices could be produced en masse as affordable disposable sensors. The transistor features thin layers of semiconductors, including indium oxide and zinc oxide, along with the enzyme glucose oxidase on top. When a saliva sample is applied to the sensor, the enzyme converts any glucose present into D-gluconolactone and hydrogen peroxide. The electrical oxidation of hydrogen peroxide generates electrons that enter the semiconductor layers, modifying the current flowing through the semiconductors. This change reflects the glucose concentration in the sample.

The researchers evaluated their device using human saliva samples with varying glucose levels and also analyzed saliva from fasting volunteers (since saliva glucose levels might not align with blood glucose levels immediately after eating). They discovered that the device accurately measured a broad range of glucose concentrations in under a minute. Importantly, the sensor remained unaffected by other molecules in saliva, including sugar derivatives like fructose and sucrose. Although the device's sensitivity decreased over time, it maintained good performance even after two weeks of storage at room temperature. The team is presently working on an array of transistor sensors that could simultaneously detect multiple metabolites in saliva.

“An easy-to-use noninvasive glucose-measuring device using saliva as a medium could be life-changing for millions of patients worldwide,” said research team member Abhinav Sharma.

“The development of portable sensor arrays that can be integrated with a smartphone is a potential future direction for research,” added Thomas Anthopoulos, who led the research team.

Related Links:
KAUST 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image:Schematic illustration of plasmonic microarray–based KRAS mutation detection from colorectal cancer patients. (Lee, J.Y., Mun, C.W., Kim, E.R. et al. npj Precision Oncology, 2026. https://doi.org/10.1038/s41698-026-01452-8)

Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations

Early-stage colorectal cancer is difficult to assess noninvasively because tumor-derived mutations occur at extremely low levels in blood and urine, straining the sensitivity, cost, and turnaround time... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.